Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed
Haplotype-based approach to known MS-associated regions increases the amount of explained risk.
Natalizumab is effective in controlling the inflammatory rebound after its discontinuation and failure of an alternative treatment.
Peptide motif for the rat MHC class II molecule RT1.Da: similarities to the multiple sclerosis-associated HLA-DRB1*1501 molecule.
Multiple sclerosis: Reprogramming the immune repertoire with alemtuzumab in MS.
Is a hypothetical melanoma-like neuromelanin the underlying factor essential for the aetiopathogenesis and clinical manifestations of multiple sclerosis?
In their own words: coping processes among women aging with multiple sclerosis.
[Multiple sclerosis and physical activity : An historical perspective.]
TNF receptor 2 protects oligodendrocyte progenitor cells against oxidative stress.
Volumetric MRI data correlate to disease severity in metachromatic leukodystrophy.
[History of Guillain-Barré Syndrome].
Evaluating individual change with the Quality of Life in Neurological Disorders (Neuro-QoL) Short Forms.
Designing an Electronic Patient Management System for Multiple Sclerosis: Building a Next Generation Multiple Sclerosis Documentation System.
Increasing female preponderance of multiple sclerosis in Isfahan, Iran: a population-based study.
Proteomic pattern analysis discriminates among multiple sclerosis-related disorders.
Engagement in a program promoting lifestyle modification is associated with better patient-reported outcomes for people with MS.
Neuropsychiatric side-effects of interferon-alpha treatment: pathophysiology and therapeutic options.
Humoral Responses to Diverse Autoimmune Disease-Associated Antigens in Multiple Sclerosis.
IL-17A activates ERK1/2 and enhances differentiation of oligodendrocyte progenitor cells.
Persistent Headache in Patients With Multiple Sclerosis Starting Treatment With Fingolimod.
Distribution of monocarboxylate transporters in the peripheral nervous system suggests putative roles in lactate shuttling and myelination.
A previously misdiagnosed cohort of aquaporin 4 antibody-positive neuromyelitis optica spectrum disorder with disease duration of >10 years in multi-ethnic Penang, Malaysia: Clinical features and disease course.
Fingolimod for multiple sclerosis and emerging indications: appropriate patient selection, safety precautions, and special considerations.
Schwann cells-axon interaction in myelination.
Saffron ethanolic extract attenuates oxidative stress, spatial learning, and memory impairments induced by local injection of ethidium bromide.
Central nervous system infectious diseases mimicking multiple sclerosis: recognizing distinguishable features using MRI.
Pages
« first
‹ previous
…
679
680
681
682
683
684
685
686
687
…
next ›
last »